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Abstract	
Bacteria	can	produce	gibberellin	plant	hormones.	While	the	bacterial	biosynthetic	pathway	is	similar	to	
that	of	plants,	the	individual	enzymes	are	very	distantly	related	and	arose	via	convergent	evolution.	The	
cytochromes	P450	(CYPs)	that	catalyze	the	multi-step	oxidation	of	the	alkane	precursor	ent-kaurene	(1)	
to	ent-kauren-19-oic	 acid	 (5),	 are	 called	ent-kaurene	 oxidase	 (KO),	 and	 in	 plants	 are	 from	 the	 CYP701	
family,	and	share	less	than	19%	amino	acid	sequence	identity	with	those	from	bacteria,	which	are	from	
the	phylogenetically	distinct	CYP117	family.	Here	the	reaction	series	catalyzed	by	CYP117	was	examined	
by	 18O2	 labeling	experiments,	 the	 results	 indicate	 successive	hydroxylation	of	1	 to	ent-kauren-19-ol	 (2)	
and	 then	 ent-kauren-19,19-diol	 (3)	 and	most	 likely	 an	 intervening	 dehydration	 to	 ent-kauren-19-al	 (4)	
prior	 to	 the	 concluding	 hydroxylation	 to	 5.	 Accordingly,	 the	 bacterial	 and	 plant	 KOs	 converged	 on	
catalysis	of	the	same	series	of	reactions,	despite	their	independent	evolutionary	origin.	
	
Introduction	
Gibberellins	 are	 essential	 plant	 hormones	 that	 regulate	 growth	 and	 development,1,	 2	 but	 are	 also	
produced	by	plant-associated	microbes,	both	fungi	and	bacteria.3	Recently	a	cytochrome	P450	(CYP)	rich	
operon,	responsible	for	gibberellin	production,	has	been	characterized	from	several	bacteria.4-7	Some	of	
these	are	beneficial	rhizobia,	which	engage	in	symbiosis	with	legumes	to	fix	nitrogen	in	specialized	root	
nodules,8	 while	 the	 others	 are	 plant	 pathogens	 that	 use	 gibberellin	 to	 suppress	 the	 plant	 defense	
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reaction	during	infection.4,	9	The	gibberellin	biosynthetic	pathway	of	plants,	fungi	and	bacteria	are	highly	
similar	 in	 their	 intermediates,	 but	 seem	 to	 have	 independently	 evolved	 as	 the	 relevant	 enzymes	 are	
either	 from	different	enzymatic	classes	or	belong	to	different	 families	within	the	same	class,	but	share	
very	low	overall	sequence	identity.5		
The	 first	 oxidative	 steps	 in	 gibberellin	 biosynthesis	 is	 carried	 out	 by	 CYPs	 termed	 ent-kaurene	
oxidases	 (KOs),	 as	 these	 produce	 ent-kaur-16-en-19-oic	 acid	 (5)	 from	 ent-kaur-16-ene	 (1),	 via	 the	
intermediates	 ent-kaur-16-en-19-ol	 (2)	 and	 ent-kaur-16-en-19-al	 (4).5	 The	 bacterial	 KOs	 are	 from	 the	
CYP117	 family,	 while	 the	 plant	 KOs	 are	members	 of	 the	 CYP701	 family	 and	 the	 fungal	 KOs	 from	 the	
CYP503	 family.2,	 10,	 11	Despite	all	 falling	within	 the	CYP	 super-family,	 these	CYP	 families	 share	 less	 than	
20%	sequence	identity	and	are	more	similar	to	other	CYP	families	from	the	same	biological	kingdom	than	
to	 each	 other5.	 Indeed,	 while	 the	 plant	 and	 fungal	 KOs	 are	 typical	 eukaryotic	 CYPs,	 with	 N-terminal	
transmembrane	helices,	the	CYP117	family	members	are	typical	soluble	prokaryotic	CYPs.	Thus,	the	plant	
and	bacterial	KOs	appear	to	have	arisen	via	independent	evolution,	in	parallel	from	the	CYP	super-family,	
despite	their	convergence	on	functionally	analogous	activity	(i.e.,	1	à	5).	
CYPs	are	heme	proteins	that	act	as	monooxygenases.	Upon	substrate	binding,	CYPs	undergo	a	one	
electron	 reduction,	 followed	by	 binding	 of	 dioxygen.	 This	 triggers	 another	 one	 electron	 reduction	 and	
formation	 of	 one	water	molecule	 and	 the	 active	 ferryl-oxo	 state	 [Fe(IV)],	 also	 called	 compound	 I.	 The	
activated	oxygen	 is	 then	most	often	 inserted	 into	a	C-H	bond.12,	 13	There	are	however	CYPs	 that	either	
catalyze	more	complex	and/or	sequential	reactions,	such	as	the	ent-kaurene	oxidases.14-17		
CYPs	that	catalyze	the	sequential	oxidation	of	a	methyl	group	to	a	carboxylic	acid	in	theory	can	do	so	
by	 any	 one	 of	 several	 pathways,	 with	 those	 for	 the	 formation	 of	 5	 from	 1	 depicted	 in	 Figure	 1.	 The	
pathway	taken	by	the	KO	from	the	plant	Arabidopsis	thaliana,	CYP701A3,	was	previously	characterized	
by	18O2	labeling	studies,10	while	the	pathway	for	the	fungal	enzyme	has	not	yet	been	investigated	in	this	
manner.	 The	 results	 indicated	 that,	 following	 initial	 hydroxylation	 of	 1	 to	 2,	 CYP701A3	 then	 further	
hydroxylates	2	to	the	di-hydroxy	ent-kaur-16-en-19-diol	(3),	that	undergoes	dehydration	to	form	4,	which	
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is	 then	 directly	 hydroxylated	 to	 produce	 5.	 However,	 although	 the	 plant	 and	 bacterial	 ent-kaurene	
oxidases	catalyze	the	same	overall	reaction	(i.e.,	1	à	5),	their	independent/parallel	evolutionary	origins	
leaves	open	the	possibility	that	they	might	use	distinct	mechanisms	(i.e.,	series	of	reactions).		
Here	the	series	of	reactions	catalyzed	by	CYP117	was	investigated	via	18O2	labeling	experiments	and	
the	 potential	 interaction	 of	 CYP117	 with	 the	 upstream	 ent-kaurene	 synthase	 was	 analyzed	 by	 a	
metabolic	engineering	approach.		
	
Results	
Previous	work	with	CYP117	family	members	from	various	bacterial	species	indicated	that	only	those	from	
plant	pathogens	are	readily	expressed	in	E.	coli.4-6	This	may	be	due	to	the	common	phylogenetic	origin	of	
these	phytopathogens	with	E.	coli,	which	all	fall	within	the	gamma-proteobacteria	class.	Given	that	one	
of	these,	Erwinina	tracheiphila,	further	falls	within	the	same	Enterobacteriaceae	family	as	E.	coli,	and	the	
CYP117	 from	 this	 species	 exhibited	 better	 activity	 in	 previous	 recombinant	whole-cell	 feeding	 studies	
with	 about	 60%	 turnover,	 this	 EtCYP117	 was	 chosen	 for	 mechanistic	 studies.	 For	 this	 purpose,	 a	
synthetic,	codon-optimized	gene	was	obtained	for	EtCYP117.	To	enable	purification,	a	number	of	His-tag	
variants	were	constructed.	Initial	whole-cell	feeding	studies	indicated	that	only	the	construct	with	a	short	
C-terminal	His-tag	was	functionally	expressed.	However,	it	was	not	possible	to	carry	out	in	vitro	assays.	
Even	with	this	optimal	construct,	cell-free	lysates	exhibited	inconsistent	activity,	did	not	bind	to	Ni-NTA	
resin,	and	instead	of	the	characteristic	absorbance	maximum	at	450	nm	after	reduction	and	CO	binding,	
a	broad	absorbance	between	400	and	410	nm	either	before	or	after	addition	of	dithionite	and/or	CO	was	
observed	(Supplemental	Figure	S1).	Accordingly,	the	studies	described	here	were	carried	out	using	this	
EtCYP117	construct	in	whole-cell	feeding	assays	conducted	under	an	18O2	atmosphere.		
To	enable	analysis	by	GC-MS,	organic	extracts	of	the	cultures	were	methylated	–	i.e.,	to	generate	the	
methyl	 ester	 derivative	of	5.	Upon	 feeding	 the	 intermediates	2	 and	4	 40-50%	 turnover	was	observed.	
However,	 only	 ~5%	 turnover	 was	 observed	 with	 1.	 When	 1	 or	 2	 were	 used	 as	 substrates	 no	
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intermediates	were	found	(i.e.,	2	or	4),	and	only	5	is	observed	as	the	product	in	all	assays	(Figure	2).	This	
indicates	that	the	intermediates	are	not	released	from	the	EtCYP117	active	site	during	the	course	of	the	
multiple	reaction	cycles	necessary	for	the	transformation	of	1	to	5.	
The	incorporation	of	18O	into	5	was	determined	via	analysis	of	the	molecular	ion	of	the	methyl	ester	
derivative	 [M+;	m/z	 316],	 as	well	 as	 two	 smaller	 fragments	 in	which	 both	 oxygen	 atoms	 are	 retained,	
namely	[M+	-15;	m/z	301]	and	[M+	-43;	m/z	273],	which	represent	the	loss	of	the	methyl	group	at	C-20	
and	loss	of	the	D-ring,	respectively.18	The	next	lower	mass	fragment	[M+	-59;	m/z	257]	is	generated	from	
the	 loss	 of	 the	 methylated	 carboxylate,	 so	 both	 oxygen	 atoms,	 and	 therefore	 the	 labels,	 are	 lost.	
Incorporation	of	18O	depended	on	the	fed	substrate	and	was	consistent	for	all	three	fragments.	Although	
in	all	experiments	~4-10%	unlabeled	5	was	observed,	this	presumably	arises	from	the	presence	of	~3%	
unlabeled	species	in	the	oxygen	source,	along	with	the	residual	oxygen	in	the	E.	coli	cultures	that	were	
used	for	these	experiments.	Thus,	with	1	it	appears	that	two	18O	were	incorporated	into	5,	while	with	2	a	
mixture	of	one	and	 two	 18O	 labels	was	observed	 (in	a	~2.6:1	 ratio),	and	with	4	only	one	 18O	 label	was	
observed	(Table	1	and	Figure	2).		
The	low	turnover	of	1	suggested	that	CYP117,	which	is	a	soluble	enzyme,	may	have	trouble	accessing	
this	 highly	 hydrophobic	 substrate,	 which	 should	 largely	 partition	 into	 the	 hydrophobic	 interior	 of	
membranes,	particularly	when	1	is	exogenously	fed.	Although	some	diffusion	and	even	volatilization	of	1	
has	been	reported,19	 in	 the	context	of	 the	 full	pathway,	 it	seemed	possible	that	CYP117	might	 interact	
with	 the	 upstream	 ent-kaurene	 synthase	 (KS)	 to	 enhance	 its	 access	 to	 1.	 This	 was	 investigated	 via	 a	
metabolic	engineering	approach	in	which	EtCYP117	was	co-expressed	with	a	KS	in	E.	coli,	also	engineered	
to	produce	 the	KS	 substrate	ent-copalyl	diphosphate.	When	using	 the	KS	 from	the	same	origin	 (i.e.,	E.	
tracheiphila,	EtKS),	 the	 relative	amount	of	1	 converted	 to	5	 by	EtCYP117	was	 increased,	 albeit	only	 to	
~10%	 (Figure	3A).	While	greater	 turnover	was	observed,	 this	modest	 increase	was	hypothesized	 to	be	
simply	 due	 to	 endogenous	 production	 of	 1	 inside,	 versus	 exogenous	 addition	 outside,	 the	 EtCYP117	
expressing	cells.	This	was	investigated	by	use	of	the	KS	from	the	plant	A.	thaliana	(AtKS),	as	this	has	very	
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low	sequence	identity,	even	over	its	single	domain	that	corresponds	to	EtKS	(AtKS	has	two	other	domains	
that	 are	 relictual20),	 and	 is	 not	 expected	 to	 interact	 with	 EtCYP117.	 While	 E.	 coli	 co-expressing	 AtKS	
instead	of	EtKS	produced	more	than	double	the	amount	of	1	and	5,	the	relative	turnover	from	1	to	5	was	
again	~10%	(Figure	3B).	Accordingly,	EtCYP117	appears	to	simply	access	its	hydrophobic	substrate	1	via	
the	presumably	relatively	small	amounts	that	diffuse	into	the	cytoplasm.	
	
Discussion		
While	 recombinantly	expressed	EtCYP117	did	not	appear	 to	be	 stably	 folded	 in	 cell-free	assays,	 it	was	
possible	 to	 probe	 the	 series	 of	 reactions	 catalyzed	 by	 this	multifunctional	 bacterial	 KO	 via	 whole-cell	
feeding	studies	carried	out	under	an	18O2	atmosphere.	Given	the	evident	initial	insertion	of	oxygen	into	
the	olefinic	 substrate	1	 to	produce	 the	alcohol	2,	 it	 is	 the	subsequently	catalyzed	 reactions	 that	are	 in	
question.	Notably,	 the	 lack	of	detectable	 intermediates	 indicates	 that	 these	are	not	 released	 from	 the	
active	site	of	CYP117	during	the	course	of	the	overall	transformation	of	1	to	5.	Moreover,	the	production	
of	doubly-labeled	5	 from	1	demonstrates	the	use	of	at	 least	two	hydroxylation	reactions,	and	rules	out	
the	 use	 of	 two	 dehydrogenation	 reactions	 (i.e.,	 2	 à	 4	 à	 3	 à	 5;	 Supplemental	 Figure	 S2	 and	
Supplemental	Table	S2).		
The	insertion	of	oxygen	from	18O2	in	the	transformation	of	4	to	5	shows	that	this	step	represents	a	
hydroxylation	reaction.	While	this	could	proceed	via	hydroxylation	of	the	equilibrating	geminal-diol	3	to	
produce	the	ortho-acid	hydrate	6	that	then	undergoes	dehydration	to	5,	the	observed	almost	complete	
labeling	 by	 18O	 is	 in	 better	 agreement	 with	 the	 expected	 100%	 incorporation	 resulting	 from	 direct	
hydroxylation	of	the	aldehyde	(Supplemental	Figure	S2	and	Supplemental	Table	S4).	Consistent	with	the	
ability	 of	 CYPs	 to	 carry	 out	 such	direct	 hydroxylation	of	 an	 aldehyde	 to	 the	 corresponding	 acid,	 it	 has	
been	previously	demonstrated	that	a	CYP	catalyzes	hydroxylation	of	11-oxo-D8-tetrahydrocannabinol	to	
an	acid	without	intervening	generation	of	the	geminal-diol.21	Use	of	the	alternative	mechanism	(i.e.,	4	à	
3	à	6	à	5)	would	require	almost	completely	selective	retention	of	the	most	recently	inserted	oxygen.		
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While	the	observed	ratio	of	2.7:1	singly-	and	doubly-	labeled	5	observed	with	2	as	the	substrate	does	
not	directly	conform	to	any	of	the	potential	reaction	series	(Supplemental	Figure	S2	and	Supplemental	
Table	S3),	the	presence	of	doubly-labeled	5	demonstrates	that	this	transformation	can	proceed	via	dual	
hydroxylation	reactions.	This	requires	loss	of	one	of	the	two	inserted	oxygens	via	dehydration,	either	of	3	
to	4	that	would	be	expected	to	lead	to	a	1:1	ratio	of	singly-	to	doubly-	labeled	5,	or	of	6	to	5	that	should	
result	 in	 a	 2:1	 ratio,	 which	 is	 closer	 to	 the	 observed	 ratio	 of	 2.6:1.	 However,	 the	 lack	 of	 complete	
selectivity	argues	against	6	à	5,	as	this	would	require	essentially	complete	retention	of	the	last	oxygen	
to	be	inserted	(as	noted	above),	along	with	preferential,	but	not	completely	selective	loss	of	one	of	the	
two	other	hydroxyl	 groups,	which	 seems	difficult	 to	envision.	 In	particular,	 if	 the	most	 recently	 added	
hydroxyl	 in	6	 is	 fixed	 in	 the	active	 site	 to	prevent	 its	 loss,	 it	 seems	most	 likely	 that	 the	hydroxyl	 to	be	
removed	also	would	be	 specified	by	 this	 strict	 binding	mode.	 It	 seems	more	plausible	 that,	 consistent	
with	the	observed	ratio,	the	hydroxyl	formed	in	conversion	of	2	to	3	is	preferentially	removed,	with	such	
dehydration	 enabling	 correct	 orientation	 of	 the	 resulting	 4	 for	 subsequent	 hydroxylation	 to	 form	 5.	
Indeed,	a	plant	KO	has	been	shown	to	stereoselectively	remove	the	pro-R	hydrogen	in	conversion	of	2	to	
4,22	 and	 stereoselective	 dehydration	 has	 been	 shown	 for	 CYP	 catalyzed	 conversion	 of	 testosterone	 to	
androstenedione,23	as	well	as	C-19	demethylation	in	estrogen	biosynthesis.24	Thus,	while	the	alternative	
dehydration	of	6	to	5	cannot	be	entirely	ruled	out,	it	seems	most	likely	that	EtCYP117	generally	proceeds	
via	stereoselective	dehydration	of	3	to	4.	Alternatively,	it	also	is	possible	that	EtCYP117	utilizes	a	mixed	
pathway,	occasionally	proceeding	via	oxidation	of	2	to	directly	form	4,	which	would	then	involve	only	a	
single	 insertion	 of	 oxygen	 and	 might	 help	 explain	 the	 prevalence	 of	 singly-labeled	 5.	 However,	
particularly	 given	 the	 requisite	 and	 demonstrated	 use	 of	 hydroxylation	 in	 the	 first	 and	 last	
transformations	 (i.e.,	 1	à	 2	 and	 4	à	 5),	 along	 with	 the	 known	 propensity	 of	 CYPs	 to	 catalyze	 such	
insertion	of	oxygen,12	it	seems	somewhat	unlikely	that	this	mechanistically	distinct	reaction	is	catalyzed	
to	 any	 significant	 extent	 by	 EtCYP117.	 Regardless,	 the	 observed	 incorporation	 of	 two	 oxygens	 in	 the	
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conversion	 of	 2	 to	 5	 demonstrates	 that	 the	 overall	 transformation	 of	 1	 to	 5	 can	 proceed	 via	 three	
hydroxylation	reactions.		
Overall,	 although	 alternative	 reaction	 series	 cannot	 be	 completely	 excluded,	 the	 results	 reported	
here	suggest	that	the	overall	series	of	transformations	catalyzed	by	EtCYP117	most	likely	is	1	à	2	à	3	à	
4	à	5.	This	implies	that	CYP117	catalyzes	three	hydroxylation	reactions	with	an	intervening	dehydration	
of	3	 to	4.	Accordingly,	both	 the	plant	and	bacterial	KOs	seem	to	catalyze	 the	same	series	of	 reactions,	
although	CYP117	appears	to	be	stereoselective	 in	the	dehydration	step,	which	contrasts	with	the	plant	
KO.10	 Regardless,	 while	 this	 congruence	 further	 highlights	 the	 similarities	 between	 the	 independently	
evolved	biosynthesis	of	gibberellins	in	bacteria	and	plants,	it	also	is	perhaps	not	so	surprising,	as	it	may	
simply	reflect	the	preferential	insertion	of	oxygen	(i.e.,	hydroxylation)	catalyzed	by	CYPs.12		
	
Experimental	
Cloning	of	CYP117	
The	 codon	optimized	 version	 of	EtCYP117	was	 a	 gift	 from	Manus	 Biosynthesis	 and	was	 PCR	 amplified	
using	Q5	 HotStart	 High-Fidelity	 DNA	 polymerase	 (NEB)	 and	 cloned	 into	 the	 Invitrogen	 pET	 expression	
system	vectors	pET100	and	pET101	(Thermo-Fisher	Scientific),	for	expression	with	either	N-	or	C-terminal	
His-Tags	encoded	by	each	vector,	 respectively.	Alternatively,	 a	6xHis-Tag	was	 inserted	before	 the	 stop	
codon	by	PCR,	and	this	construct	cloned	into	pET101.	The	primer	sequences	are	given	in	Supplementary	
Table	1.	This	latter	PCR	product	was	cloned	into	pENTR/SD/D-TOPO	(Thermo-Fisher	Scientific).	The	gene	
was	 then	 PCR	 amplified	 with	 Q5	 HotStart	 High-Fidelity	 DNA	 polymerase	 (NEB)	 and	M13	 primers,	 gel	
purified	 and	used	 for	 a	Gateway	 reaction	with	 the	Gateway	 LR	Clonase	 II	 Enzyme	Mix	 (Thermo-Fisher	
Scientific)	 and	 pCOLADuet-1/DEST,	 which	 was	 generated	 by	 restriction	 digestion	 of	 pCOLADuet-1	
(Novagen)	 with	 NcoI	 and	 NotI,	 the	 restriction	 sites	 blunt-ended	 with	 T4	 DNA	 Polymerase	 (NEB),	 and	
ligate	 with	 the	 Reading	 Frame	 A	 Cassette	 of	 the	 Gateway	 Vector	 Conversion	 System	 (Thermo-Fisher	
Scientific).		
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Expression	of	CYP117	
CYP117	in	pET100	or	pET101	was	transformed	into	E.	coli	BL21-(Star)	cells	for	expression,	3	colonies	were	
selected	for	inoculation	of	a	10	mL	starter-culture	in	NZY	medium	(10	g/L	NaCl,	10	g	/L	casein,	5	g/L	yeast	
extract,	1	g/L	MgSO4	(anhydrous),	pH	7.0)	with	50	µg/mL	carbenicillin,	which	was	incubated	for	2	days	at	
18°C	 and	 200	 rpm.	 5	 ml	 of	 the	 starter	 culture	 was	 transferred	 to	 100	 ml	 fresh	 NZY	 with	 50	 µg/mL	
carbenicillin,	 the	 culture	was	 induced	at	OD	0.8-0.9	with	1	mM	 IPTG,	and	assist	CYP	expression	1	mM	
aminolevulinic	 acid,	 1	 mM	 riboflavin	 and	 0.1	 mM	 FeCl3	 were	 added.	 After	 induction,	 cultures	 were	
incubated	at	18°C	and	200	rpm	for	12	hours.	
For	protein	purification	attempts,	recombinant	cells	were	harvested	by	centrifugation	for	30	min	at	
5000	x	g	and	taken	up	in	10	mL	50	mM	phosphate	buffer	pH	7.5,	then	lysed	either	by	freeze	thawing	with	
the	addition	of	10	mg	lysozyme	(Sigma-Aldrich),	sonication,	or	by	homogenization	with	an	EmulsiFlex	C-5	
(Avestin,	Canada).	The	resulting	lysate	was	passed	over	a	1	mL	Ni-NTA	agarose	(Qiagen),	the	column	was	
washed	with	50	mM	phosphate	buffer	pH	7.5	including	either	10	or	50	mM	imidazole.	Protein	was	eluted	
with	250	mM	imidazole	in	50	mM	phosphate	buffer	pH	7.5.	
For	metabolic	 engineering,	 E.	 coli	 C41	 OverExpress	 (Lucigen)	 cells	 were	 transformed	with	 pGGeC,	
pIRS,	pCOLA-Duet1/DEST::EtCYP117,	and	either	pET100::EtKS	or	pDEST14::AtKS.	Cultures	of	the	resulting	
recombinant	strains	were	grown	and	products	extracted	and	analyzed	as	described	previously.6,	25		
18O2	labeling	experiments		
50	ml	cultures	were	induced	at	OD	0.8	with	1	mM	IPTG	for	2	hrs	before	being	centrifuged	at	4000	x	g	for	
10	min	at	4°C	and	taken	up	in	10	mL	NZY	medium	that	had	been	freshly	degassed	under	vacuum.	Amber	
10	mL	glass	vials	were	purged	with	nitrogen,	and	then	2	ml	degassed	NZY	and	100	µL	ethanol	containing	
1	mg/mL	of	2	or	4	added.	For	1	as	substrate,	assays	used	larger	vials	(50	mL),	with	20	mL	degassed	NZY	
and	200	µL	of	ethanol	with	1	mg/mL	of	1	added.	 In	each	case,	the	vial	was	again	purged	with	nitrogen	
and	 then	 sealed	with	 a	 crimped	 rubber	 septum.	 18O2	 (97%	 labeled,	 Sigma-Aldrich,	 pressurized	 to	 less	
than	2.4	bar)	was	 introduced	 into	 the	vial	 from	the	compressed	gas	cylinder	via	a	 syringe	needle	until	
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pressure	between	 the	 tank	and	 the	 vial	 equalized.	 Then	 the	 resuspended	cells	were	added	 to	 the	 vial	
using	a	syringe.	 In	 the	case	of	assays	with	2	or	4,	200	µL	were	added,	while	 for	assays	with	1	 this	was	
increased	 to	 5	mL.	 18O2	was	 added	 two	 additional	 times,	 as	 described	 above,	 in	 time	 intervals	 of	 8	 h,	
before	the	reaction	was	stopped	by	addition	of	an	equal	volume	of	5N	HCl	as	the	cell	resuspension	(i.e.,	
200	µL	for	assays	with	2	or	4,	or	5	mL	for	assays	with	1).	The	assay	was	extracted	three	times	with	2	or	25	
mL	of	hexanes	(for	assays	with	2	or	4	versus	1,	 respectively),	which	were	combined	and	evaporated	to	
dryness.	The	residues	were	taken	up	in	200	µL	tert-butyl-methyl	ether	(Sigma-Aldrich)	and	methylated	to	
5	 with	 addition	 of	 50	 µL	 of	 a	 trimethylsulfonium	 hydroxide	 solution	 (Sigma-Aldrich).	 Products	 were	
analyzed	by	GC-MS	as	described	previously.4		
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Table	1	
	 	 	 	Percent	18O	isotopomers	-	methyl	ester	of	ent-kaurenoic	acid	(5)	
	 	
substrate	
	
m/z	
ent-kaurene	
(1)	
ent-kaurenol	
(2)	
ent-kaurenal	
(4)	
[M+	-	C3H7]	 273	 6	±	2	 7	±	2	 12	±	3	
	
			+2	 6	±	2	 68	±	4	 86	±	4	
	
			+4	 88	±	3	 25	±	3	 2	±	1	
[M+	-	CH3]	 301	 5	±	2	 5	±	2	 11	±	2	
	
			+2	 7	±	2	 70	±	4	 87	±	4	
	
			+4	 88	±	3	 26	±	3	 2	±	1	
[M+]	 316	 4	±	2	 8	±	2	 10	±	2	
	
			+2	 5	±	2	 66	±	4	 88	±	4	
	
			+4	 91	±	3	 26	±	3	 2	±	1	
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Supplemental	Table	S1:	Primers	for	cloning	of	synthetic	EtCYP117	into	pET100/pET101.		
Primer	name	 Primer	Sequence	
forward		 CACCATGGCGTTGCTGAACCCCTTTAAACG	
reverse	 TCATATGGACAGTGATCTACCTGCATCTTTTGAAAAAGC	
reverse	-stop	 TATGGACAGTGATCTACCTGCATCTTTTGAAAAAGC	
reverse	+6xHistidine	 TCAATGATGATGATGATGATGTATGGACAGTGATCTACCTGCATCTTTTGAAAAAGC	
	 Underlined	sequence	in	forward	primer	incorporated	for	dTOPO-based	cloning	method.	
	 	
	 S2	
Supplemental	Table	S2:	Potential	labeling	patterns	from	ent-kaurene,	1	(%	isotopomer).	
[M+]	 (1)	→	 (2)	→	 (3)	→	 (6)	→	 (5)	
+0	 100	 0	 0	 0	 0	
+2	 0	 100	 0	 0	 0	
+4	 0	 0	 100	 0	 100	
+6	 0	 0	 0	 100	 0	
	 (1)	→	 (2)	→	 (3)	→	 (4)	→	 (5)	
+0	 100	 0	 0	 0	 0	
+2	 0	 100	 0	 100	 0	
+4	 0	 0	 100	 0	 100	
+6	 0	 0	 0	 0	 0	
	 (1)	→	 (2)	→	 (4)	→	 (3)	→	 (5)	
+0	 100	 0	 0	 0	 0	
+2	 0	 100	 100	 100	 100	
+4	 0	 0	 0	 0	 0	
+6	 0	 0	 0	 0	 0	
	 (1)	→	 (2)	→	 (4)	→	 (5)	 	
+0	 100	 0	 0	 0	 	
+2	 0	 100	 100	 0	 	
+4	 0	 0	 0	 100	 	
+6	 0	 0	 0	 0	 	
	 (1)	→	 (2)	→	 (3)	→	 (5)	 		
+0	 100	 0	 0	 0	 	
+2	 0	 100	 0	 0	 	
+4	 0	 0	 100	 100	 	
+6	 0	 0	 0	 0	 	
	
	 	
	 S3	
Supplemental	Table	S3:	Potential	labeling	patterns	from	ent-kaurenol,	2	(%	isotopomer).	
[M+]	 (2)	→	 (3)	→	 (6)	→	 (5)	
+0	 100	 0	 0	 0	
+2	 0	 100	 0	 66	
+4	 0	 0	 100	 33	
	 (2)	→	 (3)	→	 (4)	→	 (5)	
+0	 100	 0	 50	 0	
+2	 0	 100	 50	 50	
+4	 0	 0	 0	 50	
	 (2)	→	 (4)	→	 (5)	 	
+0	 100	 100	 0	 	
+2	 0	 0	 100	 	
+4	 0	 0	 0	 	
	 (2)	→	 (3)	→	 (5)	 	
+0	 100	 0	 0	 	
+2	 0	 100	 100	 	
+4	 0	 0	 0	 	
	
	
Supplemental	Table	S4:	Potential	labeling	patterns	from	ent-kaurenal,	4	(%	isotopomer).	
[M+]	 (4)	→	 (5)	 	 	
+0	 100	 0	 	 	
+2	 0	 100	 	 	
+4	 0	 0	 	 	
	 (4)	→	 (3)	→	 (5)	 	
+0	 100	 100	 100	 	
+2	 0	 0	 0	 	
+4	 0	 0	 0	 		
	 (4)	→	 (3)	→	 (6)	→	 (5)	
+0	 100	 100	 0	 33	
+2	 0	 0	 100	 66	
+4	 0	 0	 0	 0	
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